Ce topic appartient à l'appel EIC Accelerator Challenges 2021
Identifiant du topic: HORIZON-EIC-2021-ACCELERATORCHALLENGES-01-01

Strategic Digital and Health Technologies

Type d'action : HORIZON EIC Accelerator Blended Finance
Nombre d'étapes : Multiple
Date d'ouverture : 08 avril 2021
Date de clôture :
16 juin 2021 17:00
06 octobre 2021 17:00
Budget : €496 760 000
Call : EIC Accelerator Challenges 2021
Call Identifier : HORIZON-EIC-2021-ACCELERATORCHALLENGES-01
Description :

Scope:

The EIC Accelerator Challenges supports companies (principally start-ups and SMEs) to scale up high impact innovations with the potential to create new markets or disrupt existing ones in identified areas of strategic relevance. Like EIC Accelerator Open (Section II.3 of the EIC Work Programme 2021), the EIC Accelerator Challenges focus on innovations building on scientific discovery or technological breakthroughs (‘deep tech’) and where significant funding is needed over a long timeframe before returns can be generated (‘patient capital’).

The EIC Accelerator Challenges is open to innovations in the specific fields of technology or application described by the specific challenges in sections III.3.1 and III.3.2 of the EIC Work Programme 2021. However, innovations that harm the environment or social welfare or that are designed primarily for military applications will not be supported.

You should apply to the EIC Accelerator Challenge – Strategic Digital and Health Technologies, if you believe that your company has the potential to be a global leader in developing strategic technologies in one of the following areas:

  • Digital technologies: devices, methods, systems as well as working principles, processes and standards1 which apply to the ICT technology industry such as advanced high performance computing, edge computing, quantum technologies, cybersecurity, artificial intelligence, block-chain, cloud infrastructure technologies and technologies for the Internet of Things
  • Healthcare technologies: AI-driven tools for early diagnosis; point-of-care diagnostics; novel approaches in cell and gene therapy, in particular for cancer; development of novel biomarkers for clinical prognosis, patient stratification or monitoring purposes across a wide spectrum of disorders; bioprocessing 4.0 (digitalisation across stages of biodevelopment in biotech/biopharma industry); healthcare intelligence services; and e-health (including mobile health) solutions for healthcare systems, medical practice and Intensive Care Units.

For further information, please see the EIC Work Programme 2021

_____________________________________________

1 Including such technologies provided by EU space infrastructure (Galileo, Copernicus, etc.)